These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 191877)
21. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Haslam RJ; Rosson GM Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501 [No Abstract] [Full Text] [Related]
22. Platelet accumulation on collagen: drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels. Adams GA; Feuerstein IA Thromb Haemost; 1984 Aug; 52(1):45-9. PubMed ID: 6093281 [TBL] [Abstract][Full Text] [Related]
23. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders. Gresele P; Blockmans D; Deckmyn H; Vermylen J J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542 [TBL] [Abstract][Full Text] [Related]
24. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate. Vanderwel M; Haslam RJ J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338 [TBL] [Abstract][Full Text] [Related]
25. Do human platelets have opiate receptors? Reches A; Eldor A; Vogel Z; Salomon Y Nature; 1980 Nov; 288(5789):382-3. PubMed ID: 6253832 [TBL] [Abstract][Full Text] [Related]
26. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam. Romstedt K; Huzoor-Akbar Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062 [TBL] [Abstract][Full Text] [Related]
27. The effect of hypercholesterolaemia on the lipid composition and ability of human platelets to accumulate cyclic AMP. Jakubowski JA; Ardlie NG; Nestel PJ Prostaglandins Med; 1980 Dec; 5(6):457-67. PubMed ID: 6258183 [TBL] [Abstract][Full Text] [Related]
29. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Haslam RJ; Davidson MM; Desjardins JV Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136 [TBL] [Abstract][Full Text] [Related]
31. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. Beretz A; Stierle A; Anton R; Cazenave JP Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405 [TBL] [Abstract][Full Text] [Related]
32. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man]. Ardelt W Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100 [TBL] [Abstract][Full Text] [Related]
38. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets. Griffiths RJ; Moore PK Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281 [TBL] [Abstract][Full Text] [Related]
39. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets. Zahavi M; Zahavi J; Kakkar VV Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838 [TBL] [Abstract][Full Text] [Related]
40. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164. Allan G; Levi R J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]